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Abstract
Background: Overweight and obesity are significant public health concerns that are 
prevalent in younger age cohorts. Preventive or therapeutic interventions are difficult to 
implement and maintain over time. On the other hand, the majority of adolescents in the 
United States have a smartphone, representing a huge potential for innovative digitized 
interventions, such as weight loss programs delivered via smartphone applications. 
Although the number of available smartphone applications is increasing, evidence for 
their effectiveness in weight loss is insufficient. Therefore, the proposed study aims to 
assess the efficacy of a gamification-based smartphone application for weight  
loss in overweight and obese adolescents. The trial is designed to be a phase II,  
single-centre, two-arm, triple-blinded, randomized controlled trial (RCT) with a  
duration of 6 months.
Method: The intervention consists of a smartphone application that provides both tracking 
and gamification elements, while the control arm consists of an identically designed 
application solely with tracking features of health information. The proposed trial will be 
conducted in an urban primary care clinic of an academic centre in the United States of 
America, with expertise in the management of overweight and obese adolescents. Eligible 
adolescents will be followed for 6 months. Changes in body mass index z score from baseline 
to 6 months will be the primary outcome. Secondary objectives will explore the effects of 
the gamification-based application on adherence, as well as anthropometric, metabolic and 
behavioural changes. A required sample size of 108 participants (54 participants per group) 
was calculated.
Discussion: The benefits of the proposed study include mid-term effects in weight reduction 
for overweight and obese adolescents. The current proposal will contribute to fill a gap 
in the literature on the mid-term effects of gamification-based interventions to control 
weight in adolescents. This trial is a well-designed RCT that is in line with the Consolidated 
Standards of Reporting Trials statement.
Keywords: adolescents, clinical trial, gamification, obesity, overweight, smartphone application, 
study protocol, weight loss
Received: 19 February 2018; revised manuscript accepted: 19 March 2018.
Correspondence to: 
Patrick Timpel  
Prevention and Care 
of Diabetes Mellitus, 
Department of Medicine III, 
Faculty of Medicine Carl 
Gustav Carus, Technische 
Universität Dresden, 
Fetscherstrasse 74, 
Dresden 01307, Germany 
patrick.timpel@tu-
dresden.de
Fernando Henpin Yue 
Cesena  
Hospital Israelita Albert 
Einstein, São Paulo, SP, 
Brazil
Christiane da Silva Costa  
Brazilian Health 




Department of Radiology, 
Hospital das Clínicas de 
Porto Alegre, Faculdade 
de Medicina, Universidade 
Federal do Rio Grande 
do Sul, Porto Alegre, RS, 
Brazil
Emanuel Gois Jr  
Department of Surgery, 
State University of 
Londrina, Brazil; Pontifical 
University of Parana, 
Brazil
Eduardo Castrillon  
Departamento de Clínicas 
Médicas, Pontificia 
Universidad Javeriana de 
Cali, Cali, Colombia
Lina Johana Jaime Díaz  
Clínica Universidad de la 
Sabana, Bogotá, Colombia
Gabriela M. Repetto 
Center for Genetics and 
Genomics, Facultad 
de Medicina, Clínica 
Alemana Universidad del 
770938 TAE0010.1177/2042018818770938Therapeutic Advances in Endocrinology and MetabolismP Timpel, FHY Cesena
research-article2018
Study Protocol
Therapeutic Advances in Endocrinology and Metabolism 9(6)
168 journals.sagepub.com/home/tae
Introduction
Obesity in childhood and adolescence is a current 
public health challenge that is rising worldwide.1,2 
Although prevalence in adolescents worldwide is 
uncertain and variable across regions and coun-
tries, among adolescents living in the United States 
(US), aged 12–19 years, obesity has increased from 
5% in 1976 to over 18.4% in 2010. These growing 
rates in the US are even more profound in Black 
and Latino groups, exceeding 20%.3 According to 
the National Health and Nutrition Examination 
Survey 2009–10 (NHANES) overweight and obe-
sity in this age (12–19) bears nearly 30% overall, 
showing also sex, geographic and socioeconomic 
discrepancies.4,5 Studies in paediatric populations 
have demonstrated the importance of lifestyle pro-
grams on the management of obesity, and its rela-
tion to self-learning of healthy habits, self-monitoring 
of food intake and physical activity, to improve 
health outcomes.6,7 However, treatments in this age 
group face difficulties such as high attrition, poor 
adherence, and complex programs, limiting the 
efficacy of weight control treatments.8,9
In the US, 78% of teenagers have a smartphone, 
demonstrating a huge potential for digitized cardio-
vascular prevention and health promotion in the 
youth.10 Studies show that technology-based inter-
ventions on weight loss and quality of life for patients 
suffering from overweight or obesity are more effi-
cient than standard care in the short term.11 The use 
of mobile applications can be beneficial in monitor-
ing patients’ health behaviour, chronic disease symp-
toms, promoting medication adherence and raising 
self-awareness.12 Mobile and multimedia technolo-
gies also show a promising opportunity to enhance 
healthcare knowledge, health promotion and disease 
prevention. Systematic reviews show that technol-
ogy-based interventions might be valid tools for 
weight loss, leading to higher program adherence 
and improved monitoring.12–14 Furthermore, smart-
phone applications may represent an option to 
improve health habits, and to motivate for physical 
activity and weight loss using gamification.15,16 A 
systematic review of game-based interventions in 
rehabilitation of diabetic patients showed a signifi-
cant effect on health-related quality of life, balance, 
and strength, although there was no effect on gly-
cated haemoglobin.17
Although many mobile applications claim to 
improve health outcomes, such as supporting 
weight loss, efficacy evidence and gamification 
methodological quality is insufficient.12,14,17–19 
Other groups underline the need for full-scale 
summative evaluation studies of existing games.20 
Despite the increasing interest in studying tech-
nology-based tools to prevent or manage obesity 
and overweight in adolescent, a lack of trials, 
small sample sizes and mixed results are still ham-
pering a more standardized and evidence-based 
approach to this target population.21 Additionally, 
trials using standardized evaluations are limited 
and mostly focus on adult populations.22
Therefore, this study aims to assess the efficacy of 
a gamification-based smartphone application for 
weight loss in overweight and obese adolescents 
using a single-centre, two-arm, triple-blinded, 
phase II randomized controlled trial (RCT). The 
application combines tracking (monitoring) and 
gamification to develop a healthy lifestyle and can 
be a tool in the management of obesity in children 
and teenagers. In this trial protocol, a hypotheti-
cal smartphone application is considered.
Methods
Trial design
The trial will be a phase II, single-centre, two-
arm, triple-blinded, RCT with a duration of 6 
months. The proposed trial protocol was devel-
oped to answer the following research question: 
does a 6-month intervention, based on the use of 
a gamification-based smartphone application, on 
top of standard care, help overweight and obese 
adolescents to lose weight, in comparison with 
the combination of a passive tracking application 
and standard care alone? Figure 1 illustrates the 
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Figure 1. PICOT.
BMI, body mass index; PICOT, population, intervention, comparison, outcome, time.
P = Overweight and obese adolescents (12-18 years), from a primary care center in the USA
I  = Use of a gamification-based smartphone application with tracking function + standard care
C = Use of a passive tracking application + standard care
O = BMI z score change
T  = 6 months
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PICOT23 (population, intervention, comparison, 
outcome, time) details for the proposed study.
Study setting
The trial will be conducted in an urban primary 
care clinic of an academic centre in the USA, with 
expertise in the management of overweight and 
obese adolescents.
Eligibility criteria
Patients who fulfill the following inclusion criteria 
will be eligible to be enrolled in the study:
 • 12–18 years old
 • Fluent in English (due to study setting and 
language of the app)
 • Overweight [body mass index (BMI)-for-
age > +1 standard deviation (SD)] or 
obese (BMI-for-age > +2 SD), according 
to the World Health Organization 
definition24,25
 • Daily access to a smartphone.
Patients fulfilling any of the following criteria will 
be excluded from the trial:
 • Secondary causes of obesity (e.g. endocrine 
abnormality)
 • Chronic diseases such as cardiovascular dis-
eases, renal diseases, liver diseases, obstruc-
tive pulmonary diseases, classic symptoms of 
hyperglycaemia (polyuria, polyphagia, poly-
dipsia and weight loss)
 • Severe acute illness, children receiving 
chemotherapy
 • Patients on pharmacologic intervention 
for weight reduction, children already 
participating in weight loss programs 
or already using lifestyle-targeting 
application
Figure 2. Features of the application in the 






Exercise tracking  
Food intake tracking  
Figure 3. CONSORT flowchart of the suggested trial.
CONSORT, Consolidated Standards of Reporting Trials
 • Patients that underwent any metabolic 
surgery
 • Obstructive sleep apnoea
 • Genetic syndromes
 • Neurodevelopmental abnormality, mental 
health disorders
 • Long-term use of medications
 • Neurological and physical disability.
Interventions
The intervention consists of a hypothetical smart-
phone application that provides both tracking and 
gamification elements, while the control arm con-
sists of an identically designed application with 
solely tracking features of health information 
(Fig. 2).
Eligible patients will be randomized to use a 
specific smartphone application on top of stand-
ard care for a 6-month period. The hypothesis is 
that specific application features will improve 
engagement in lifestyle changes towards weight 
loss. The application uses a personalized approach 
and involves games and activities to educate chil-
dren and adolescents about healthy eating and 
physical activity.
The application comprises tracking and moni-
toring functions using diaries of food intake 
(calories consumed each day in each meal), 
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exercises (type and duration) and daily steps. 
Additionally, elements of gamification, such 
as challenges and points systems, are used in 
order to promote healthy nutrition choices and 
exercises.
Standard care will be left to the attending physi-
cian’s discretion in consonance with recommenda-
tions by 2017 Endocrine Society Clinical Practice 
Guideline on Paediatric Obesity,26 in which weight 
loss medications are not a part of initial manage-
ment of obesity.
Standard care comprises monthly office visits as 
well as planned reinforcement for achieving targeted 
behaviour; a planned diet by a dietitian or a clinician, 
with balanced macronutrients in proportion with die-
tary reference intake recommendations; reduction of 
television and other screen time to less than an hour; 
supervised, planned, physical activity for 60 min per 
day.27
Adherence
To increase adherence, both the control and 
intervention arm will receive text messages one 
week prior to clinic appointments as well as phone 
contact the day before. Centers will provide an 
opportunity to reschedule missed appointments 
within 1 week.
A 1-month run-in period will be used to evaluate 
participants’ motivation and to educate partici-
pants on how to use the basic smartphone appli-
cation (without gamification features), prior to 
randomization.
Process evaluation, as a part of the secondary 
analysis, will be measured to assess adherence of 
included participants. Interactions with the appli-
cation (utilization) per week, time using the appli-
cation and number of attendance to appointments 
will be recorded.
Timeline
After study enrollment, the eligibility criteria will 
be assessed for each participant according to the 
baseline clinical assessment in the first visit (Fig. 3). 
Written informed assent and consent will be taken 
from all participants and their parents or legal 
guardian, respectively.
Participants will be followed up for 6 months. 
Data for the primary outcome will be assessed at 
baseline and after 6 months while data for sec-
ondary outcomes will be collected monthly.
Randomization
Patients will be randomized to either the experi-
mental or control arm with a 1:1 allocation ratio, 
through an online central randomization service. 
The randomization process will use permuted 
blocks of four, stratified according to school, in 
order to prevent covariate imbalances between 
groups. Allocation concealment will be ensured, 
as the service will not release the randomization 
code until the end of the trial. Access to the appli-
cation will be given by independent access per-
sonnel. Throughout the study, the randomization 
will be conducted by the independent service 
account for blinding of data manager and 
statistician.
Blinding
The study will be designed as a triple-blinded 
trial. Participants, treating physicians and dieti-
tians, as well as outcome evaluators and data ana-
lysts will be blinded.
Participants in both arms will receive standard 
care and access to a smartphone application that 
will be identical in terms of interface style and 
design. Care providers will participate in an 
intense training program before entering the 
study. Independent research personnel, not 
involved in patient care, will give access to the 
application to each participant. Blinding will be 
supported by the similarities of the smartphone 
application versions used for the intervention 
group and the control groups in terms of design 
and function.
To evaluate the robustness of blinding, partici-
pants will be asked after the trial ends to which 
group they anticipate they were initially assigned 
to.
Sample size calculation
In the light of observational study results, an 
expert panel of the US Preventive Services Task 
Force recommends a BMI z score reduction in 
the range of 0.20 to 0.25 to be a suitable thresh-
old for clinically important changes.28 Considering 
a clinically meaningful difference of 0.25, power 
of 80%, α-level of 0.05, and a potential dropout 
rate of 20%, obtained from previous trials of 
P Timpel, FHY Cesena et al.
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similar methodology,29,30 a required sample size 
of 108 participants (54 participants per group) 
was calculated.
Recruitment
Recruitment will be based on two parallel strate-
gies. Advertising in schools belonging to the dis-
trict of the relevant primary care center will be 
conducted using posters, leaflets and a webpage. 
Additionally, teachers from the schools situated in 
the relevant districts will be involved.
In addition to school-based advertisements, the 
primary care center itself will be involved using 
posters, leaflets and a webpage. Practitioners and 
health staff will be motivated to approach patients 
during routine appointments.
Primary objective
The primary objective will be to determine if the 
gamification-based intervention delivered via a 
smartphone application plus standard care is 
superior to standard care combined with a track-
ing application in reducing BMI z score (as a 
measure adjusted for age and sex) from baseline 
to 6 months.
Secondary objectives
Measurements for secondary objectives will 
explore the effects of the gamification-based 
application on adherence, as well as on anthropo-
metric, metabolic and behavioural changes. 
Including aspects derived from the Health Action 
Process Approach by Schwarzer and Fuchs will 
increase the understanding of the behaviour 
change process.31
In addition to the primary measurement, BMI z 
score will also be evaluated monthly to support 
understanding of behaviour change. Monthly 
anthropometric changes in the body shape index 
(ABSI, waist circumference normalized to height 
and weight) will also be verified. To assess cardio-
vascular risk factors, blood pressure, lipids and 
glycaemic status (fasting plasma glucose, glycated 
haemoglobin, insulin) will be evaluated at base-
line and after 6 months.
On top of that, steps will be counted by a built-
in feature of the application and a physical activ-
ity questionnaire for adolescents (PAQ-A) will 
be applied. This information will allow for clas-
sifying adolescents into different physical activ-
ity clusters and will help to investigate the 
connection between physical activity, health 
behaviour and health-related outcomes.32 
Measurements of service utilization will be per-
formed at baseline as well as after 3 and 6 
months to support the understanding of the 
behaviour change process.
Readiness to change lifestyle, self-efficacy (‘gen-
eralized self-efficacy scale’) and quality of life 
[‘impact of weight on quality of life-kids’ 
(IWQOL-Kids)] will be measured. The IWQOL 
is a 27-item, self-administered, brief (taking 
around 8 min) and weight-related measure to 
assess quality of life in adolescents.33 Self-
efficacy is seen as an indicator for coping strate-
gies and confidence in weight loss treatments.34 
The generalized self-efficacy scale developed by 
Schwarzer and colleagues will be applied.35 It 
will be enriched by using dimensions of accurate 
measurements appropriate for the target group 
in terms of age, sex and ethnic differences to 
cover specific elements of physical exercise 
self-efficacy.36,37
Adherence will also be analyzed by evaluating the 
self-reported frequency of application utilization 
and its most relevant features using a structured 
questionnaire.
Statistical analysis
The primary and secondary outcomes will be 
analyzed and compared between the two study 
groups. Distribution of data will be analyzed by 
visual (histograms and SD) and statistical nor-
mality tests (Shapiro–Wilk).
Changes in BMI z score from baseline to 6 
months will be compared using an unpaired t test 
(Table 1). In the analysis of secondary outcomes, 
continuous variables will be analyzed with an 
unpaired t test, ordinal data will be analyzed using 
a Mann–Whitney U test and, for categorical vari-
ables, Fisher’s exact test or Chi-square test will be 
applied (Table 1).
Analysis and reporting will be in line with the 
Consolidated Standards of Reporting Trials 
(CONSORT) guidelines for reporting parallel 
group RCTs.38 No interim analysis will be 
performed.
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Missing data
Data will be analyzed on an intention to treat 
basis. Missing data will be handled through mul-
tiple imputation. A sensitivity analysis will be 
carried out considering a worst-case scenario 
(i.e. patients did not lose any weight during the 
trial).
Data management
Patient data and profiles will be protected with 
an individual code only the principal investigator 
will have access to. The patient’s profiles and col-
lected data will be stored on secure servers using 
only password-protected computers, only availa-
ble for personnel approved by the Institutional 
Review Board (IRB). No formal data monitoring 
committee will be installed as there is no safety 
concern.
Withdrawal and stopping rules
Patients will be free to withdraw from the study 
whenever they want. If they decide to withdraw, 
they will be asked to attend the follow-up meas-
urement after month 6 and provide data. No fur-
ther data will be collected if participants refuse to 
attend the follow-up measurement or refuse to 
provide data.
No stopping rules will be defined, as the interven-
tion will not ask adolescents to do anything 
beyond standard care and using a smartphone 
application providing tracking (physical activity 
and diet) and gamification. Nevertheless, all 
adverse events will be documented and evaluated 
in terms of causality.
Discussion
The main aim of the proposed RCT is to assess 
the efficacy of a smartphone application with a 
gamification approach for healthy lifestyle pro-
motion, to help overweight and obese adolescents 
to reduce weight. The hypothetical smartphone 
health application is designed specifically for chil-
dren and teenagers, to help in self-monitoring of 
food habits and physical activity in order to 
develop a healthy lifestyle. Benefits of the pro-
posed study include the evaluation of mid-term 
effects in weight reduction for overweight and 
obese adolescents, which is also relevant for 
future trial protocols.
A recent systematic review on the evaluation of 
smartphone applications for health behaviour 
change summarized that no single best practice 
approach can be suggested to evaluate mobile 
health apps due to insufficient data, leading to 
potentially incomplete and inaccurate guidance.39 
As reported by Neugebauer and colleagues there 
are specific barriers to the conduct of RCTs on 
medical devices including matters of trial design, 
such as randomization, acceptability, blinding, 
determining appropriate outcomes.40 Accordingly, 
the study group carefully designed the proposed 
trial aiming to minimize the risk of bias.
The current study will address multiple gaps in 
the literature, such as missing data on the mid-
term effects of smartphone interventions. The 
efficacy of innovative treatment strategies, like 
gamification, will be analyzed due to their current 
heterogeneity in terms of contents and method-
ologies of interventions and studies.41 Due to 
Table 1. Statistical analysis of outcomes.
Outcome Statistical test
Primary  




Monthly BMI z score Repeated measures 
ANOVA
ABSI Unpaired t test
Blood pressure Unpaired t test
Glucose, lipidsa Unpaired t test
IWQOL-Kids Mann–Whitney U test
PAQ-A Mann–Whitney U test
Self-efficacy Unpaired t test
Step counts Unpaired t test
Self-reported frequency 
of application utilization 




ABSI, A body shape index (WC normalized to height and 
weight); ANOVA, analysis of variance; BMI, body mass 
index; IWQOL-Kids, impact of weight on quality of life-kids; 
PAQ-A, physical activity questionnaire for adolescents; WC, 
waist circumference.
aTriglycerides will be log-transformed to improve 
normalization of the distribution.
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their potential to improve the reach and access to 
target populations, the trial uses a smartphone 
application.42 However, to this day there is no 
clear understanding of the processes through 
which such applications work.43 It is a huge chal-
lenge for study designs to investigate these com-
bined mechanisms singularly. In the proposed 
study protocol this challenge is addressed by the 
introduction of a passive application that enables 
a more specified investigation of the active 
treatment.
Due to the repetitive nature of games (e.g. video 
games), the potential of promoting health-related 
learning can be of special benefit for children.44,45 
The suggested application combines multiple 
components including monitoring, tracking and 
gamification. The proposed protocol will provide 
further knowledge on the efficacy of combining 
functionalities within one intervention in over-
weight and obese children.
Although designed as a triple-blinded RCT, un-
blinding will be a serious threat in this trial. 
Participants may guess that they are in the control 
arm when talking to other participants of the 
study. However, the study group addressed this 
challenge by introducing a sham-like application 
in the control arm that will have an identical 
design as the smartphone application used in the 
intervention group, in order to lower the risk of 
dropout and un-blinding. Similarly, low adher-
ence may hamper the study feasibility. However, 
the study group will address this issue in multiple 
ways, such as establishing multiple application 
features, structured reminders for appointments 
and the fact that the intervention is accessible on 
a 24-hour basis. Maintenance of blinding and 
concealment is also supported by separating ran-
domization from the treating professionals and 
restricting the access to the randomization code 
until the end of the project.
A 6-month follow-up protocol will be chosen, 
assuming this is a reasonable period to detect 
meaningful changes in BMI z score. Indeed, this 
is the duration frequently used in studies investi-
gating behaviour changes.46,47 However, the 
effects of the intervention may not be sustained 
over time. In this regard, monthly measurements, 
as well as information on application usage and 
self-reported feedback by the participants will 
allow developing a deeper understanding of pro-
gressive effects of the intervention up to 6 months.
A recent review on the effect of smartphone 
applications on glycaemic control improvement 
summarized that the functionality and applica-
tion of the technology require standardization. 
The authors also call for policy and guidance.48 
The developed trial protocol has the potential to 
provide such guidance by presenting a high-
quality approach to test technological solutions 
for specific target groups, such as overweight 
and obese adolescents, which allows gaining a 
deeper understanding for these emerging tech-
nologies and their possible benefits for specific 
populations.
The developed framework of this protocol is in 
line with the CONSORT statement38 and pro-
vides new strategies of dealing with smartphone 
applications in clinical research. The proposed 
study protocol can be used by other groups that 
aim to generate efficacy data evaluating smart-
phone applications for the management of obe-
sity and other chronic metabolic conditions in 
adolescents.
In conclusion, this protocol intends to evaluate an 
innovative, cheap, increasingly popular interven-
tion (smartphone application) aimed to help con-
trol a relevant condition, that is, obesity in the 
young, focussing on a specific, novel aspect of 
mobile interventions (gamification). The pro-
posal is a well-designed RCT based on standard-
ized, robust procedures and following the most 
rigorous requirements in scientific investigation.
Trial status
At the time of submission, the trial was at the 
planning stage and had not yet started recruiting 
patients. The protocol will be registered in an 
online clinical trial database before starting with 
the trial. The protocol will be presented to an IRB 
for approval.
The study protocol was developed based on 
intense discussions of international young scien-
tists taking part in a distance learning program in 
the field of clinical research. Due to their affilia-
tions in heterogeneous disciplines, the developed 
study protocol is intended to be a methodological 
contribution rather than a protocol of a trial that 
will be effectively conducted by the present group 
of authors. The results of this proposed trial may 
provide guidance for clinical practice and this 
protocol can be used by other groups.
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